Search - tctmd.com

Displaying 1 - 20 of 106

Sort: Relevancy | Date

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Daily News

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Yael L. Maxwell

January 21, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Daily News

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

Todd Neale

August 25, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Todd Neale

April 28, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

US Football Fans Are Flooded With Ads for Unhealthy Foods

Michael O'Riordan

January 30, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

Advertisement

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Year in Review: Top Prevention Stories of 2025

Year in Review: Women’s Heart Health in the Spotlight

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

GLP-1 Drugs May Have Role in Secondary Prevention of AF

April 2025 Dispatch for the CV Team

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

US Football Fans Are Flooded With Ads for Unhealthy Foods

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

November 2024 Dispatch for the CV Team

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Statins Effective For Primary Prevention in Old and Very Old

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content